Integrated Antihypertensive and Statin Treatment Protocols for Cardiovascular Disease Prevention in Low- and Middle-Income Countries.

Autor: Moran AE; Resolve to Save Lives, New York, USA.; Columbia University Irving Medical Center, New York, USA., Aimiosior O; Resolve to Save Lives, New York, USA., Gupta R; Resolve to Save Lives, New York, USA.; University of California at San Francisco, San Francisco, USA., Pathni A; Resolve to Save Lives, New Delhi, India., Sahoo SK; Resolve to Save Lives, New Delhi, India., Dessie G; Resolve to Save Lives, Addis Ababa, Ethiopia., Osi K; Resolve to Save Lives, Abuja, Nigeria., Zhang X; Vital Strategies, Jinan, China., Banigbe B; Resolve to Save Lives, New York, USA., Garg R; Resolve to Save Lives, New York, USA., Frieden TR; Resolve to Save Lives, New York, USA.
Jazyk: angličtina
Zdroj: Global heart [Glob Heart] 2024 Dec 10; Vol. 19 (1), pp. 93. Date of Electronic Publication: 2024 Dec 10 (Print Publication: 2024).
DOI: 10.5334/gh.1376
Abstrakt: In low- and middle-income countries where the majority of preventable cardiovascular disease deaths occur, less than 10% of eligible patients receive statins for primary cardiovascular disease prevention. Since 2017, the Global Hearts initiative has implemented simple World Health Organization (WHO) HEARTS hypertension and diabetes treatment protocols. In this editorial, we propose an approach of integrating statin treatment into existing HEARTS hypertension and diabetes protocols as a way of expanding statin coverage in low-and middle-income countries.
Competing Interests: The authors have no competing interests to declare.
(Copyright: © 2024 The Author(s).)
Databáze: MEDLINE